Cite
Sato Y, Kobayashi T, Nishiumi S, et al. Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Cancers (Basel). 2020;12(9)doi: 10.3390/cancers12092625.
Sato, Y., Kobayashi, T., Nishiumi, S., Okada, A., Fujita, T., Sanuki, T., Kobayashi, M., Asahara, M., Adachi, M., Sakai, A., Shiomi, H., Masuda, A., Yoshida, M., Takeuchi, K., Kodama, Y., Kutsumi, H., Nagashima, K., & Honda, K. (2020). Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Cancers, 12(9), . https://doi.org/10.3390/cancers12092625
Sato, Yu, et al. "Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer." Cancers vol. 12,9 (2020). doi: https://doi.org/10.3390/cancers12092625
Sato Y, Kobayashi T, Nishiumi S, Okada A, Fujita T, Sanuki T, Kobayashi M, Asahara M, Adachi M, Sakai A, Shiomi H, Masuda A, Yoshida M, Takeuchi K, Kodama Y, Kutsumi H, Nagashima K, Honda K. Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Cancers (Basel). 2020 Sep 14;12(9). doi: 10.3390/cancers12092625. PMID: 32937962; PMCID: PMC7564617.
Copy
Download .nbib